Does LEUPROLIDE Cause Device leakage? 5,861 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5,861 reports of Device leakage have been filed in association with LEUPROLIDE (Fensolvi). This represents 8.3% of all adverse event reports for LEUPROLIDE.
5,861
Reports of Device leakage with LEUPROLIDE
8.3%
of all LEUPROLIDE reports
7
Deaths
8
Hospitalizations
How Dangerous Is Device leakage From LEUPROLIDE?
Of the 5,861 reports, 7 (0.1%) resulted in death, 8 (0.1%) required hospitalization.
Is Device leakage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 5,861 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
Off label use (2,060)
What Other Drugs Cause Device leakage?
SOMATROPIN (9,113)
EXENATIDE (5,115)
PEGFILGRASTIM (1,380)
ALBIGLUTIDE (1,195)
SECUKINUMAB (910)
RISPERIDONE (878)
TREPROSTINIL (874)
DEVICE (795)
GUSELKUMAB (712)
ABATACEPT (671)
Which LEUPROLIDE Alternatives Have Lower Device leakage Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM